检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:杨剑锋[1] 彭绍华[1] 陈森林[2] 谢平平[1]
机构地区:[1]湖南师范大学医学院病理教研室,湖南长沙410006 [2]湖南省肿瘤医院病理科
出 处:《中国医师杂志》2004年第2期170-172,共3页Journal of Chinese Physician
基 金:湖南省卫生厅科研基金资助项目 (B2 0 0 3 - 1 1 7)
摘 要:目的 探讨上皮性钙粘素 (E -cd)及α -、β -连接素 (cat)在乳腺癌组织及淋巴结转移灶中的表达及意义。 方法 免疫组化S -P法检测 60例乳腺癌 ( 3 1例有淋巴结转移 )及相应淋巴结转移灶中E -cd、α -、β -cat的表达。 结果 60例乳腺癌组织中E -cd、α -、β -cat异常表达率分别为 5 1 7%、61 7%、70 %,E -cd的表达与乳腺癌淋巴结转移显著相关 ( P <0 0 0 5 ) ,α -、β -cat的表达与淋巴结转移无关。淋巴结转移灶中E -cd表达较相应原发灶明显增强 (P <0 0 0 5 ) ,淋巴结转移灶中α -、β -cat的表达与原发灶无显著差异。结论 原发灶E -cd的下调使癌细胞脱离原发灶 ,而转移灶内E -cd重新表达可能利于癌细胞黏附于远处器官 。Objective To investigate the protein expressions of E-cadherin and α-,β-catenin in breast cancers and their lymph-node metastatic tumors to evaluate their possible role in breast cancer invasion and metastasis. Methods High sensitive S-P immunohistochemical method was used to detect the protein expressions of E-cadherin and α-,β-catenin in 60 breast cancers(31cases with lymphatic metastasis) and their lymph-node metastatic tumors. Results The abnormal expression rates of the E-cadherin and α-,β-catenin were 51 7%, 61 7%, 70% respectively in the 60 cases of breast cancers. The expression of E-cadherin was significantly associated with lymphatic metastasis(P<0 05). However, there was no significant relationship between α-,β-catenin expression and lymph node metastasis. Expression of E-cadherin in metastatic lesion was significantly higher than that in primary tumor, while there was no significant difference in α-,β-catenin expressions between the primary tumor and metastatic lesion. Conclusions Down-regulation of E-cadherin may promote the tumor cells to release from the primary site, and re-expression of E-cadherin may be important for tumour cells to adhere in remote organs and to form metastatic tumors.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.200